 REDWOOD CITY, Calif.--BUSINESS WIRE--Guardant Health, Inc. Nasdaq: GH, a leading precision oncology company, today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit. Guardant Healths management is scheduled to participate in a fireside chat on Tuesday, August 10 at 4:00 p.m. Pacific Time 7:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the Investors section of the company w 